Print

HVTN 088

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

Trial Details:

I Completed
HIV Vaccine Trials Network (HVTN), Novartis
Oligomeric gp140/MF59 Env gp140 B
Oligomeric gp140/MF59 Protein
MF59
USA 40
NCT01376726
http://clinicaltrials.gov/ct2/show/NCT01376726?term=hiv+vaccine&lup_s=06%2F15%2F2011&lup_d=30